• Time-resolved CT Angiography for the Detection and Classification of Endoleaks

    Radiology: Volume 263: Number 3-June 2012

    Wieland H. Sommer, MD Christoph R. Becker, MD Mareike Haack, MD Geoffrey D. Rubin, MD Rolf Weidenhagen.MD Florian Schwarz, MD Konstantin Nikolaou, MD Maximilian F. Reiser, MD Thorsten R. Johnson, MD Dirk A. Clevert, MD

    Purpose: To assess the feasibility and diagnostic performance of time-resolved computed tomographic (CT) angiography in the detection and classification of endoleaks after en­dovascular aortic aneurysm repair (EVAR) in high-risk patients.

    Materials and methods: The study was approved by our ethics committee. Written informed consent was obtained from all participating pa­tients. Fifty-four patients (42 male and 12 female patients; mean age, 70.9 years ± 9.3 [standard deviation]) with either thoracic (n = 8) or abdominal (n = 46) aortic an­eurysms treated with a stent-graft were prospectively in­cluded. The patients were examined with a time-resolved CT angiographic protocol consisting of 12 low-dose phases (80 kVp; 120 mAs [effective]; scan range, 27 cm), with 60 mL of iomeprol. Patients with abdominal aneurysm repair also underwent contrast material-enhanced (CE) ultrasonography (US). The time delay between contrast enhancement within the stent lumen and the endoleak was measured. Effective radiation dose was calculated from the scanner protocols. Measures of diagnostic per­formance for the detection of endoleaks were calculated for time-resolved CT angiography, with CE US serving as the reference standard.

    Results: All time-resolved CT angiographic data sets were diagnos­tic. Mean effective radiation dose was 14.6 mSv. Four tho­racic and 19 abdominal endoleaks were identified by using time-resolved CT angiography. Seventeen of 19 abdominal endoleaks were confirmed with CE US. This rate resulted in a sensitivity of 94%, a specificity of 93%, a positive predictive value of 89%, and a negative predictive value of 96% for time-resolved CT angiography after abdomi­nal EVAR. Type I endoleaks showed significantly earlier mean peak contrast enhancement (0.28 second ± 0.83) compared with that for type II endoleaks (9.17 seconds ± 3.59, P< .0001).

    Conclusion: Time-resolved CT angiography with 12 low-dose phas­es is feasible for patients after thoracic and abdominal EVAR. The protocol approximates the radiation dose of standard triphasic protocols. Its dynamic information dif­ferentiates types of endoleaks and shows high diagnostic performance.